Κυριακή 12 Φεβρουαρίου 2023

A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen

AlexandrosSfakianakis shared this article with you from Inoreader
via Vaccine

fbworm.png

CONCLUSION: nAbs are efficiently elicited by heterologous AZD1222/BNT162b2 vaccination, as well as prior infection/vaccination, whereas spike-specific CD4+T-cell responses are efficiently elicited by homologous BNT162b2 vaccination. Variant-recognizing immunity is more efficiently generated by prior infection/vaccination than the other homologous or heterologous vaccination regimens.PMID:36754764 | PMC:PMC9901539 | DOI:10.1016/j.vaccine.2023.01.063 (Source: Vaccine)
View on Web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου